Activity Description
This asynchronous course provides optometrists with comprehensive education on etiology, diagnosis, and treatment options for the management of eyelid margin diseases, corneal nerve dysfunction, and other ocular inflammatory conditions. Attendees can expect clear, implementable guidance drawn from case presentations and interactive discussion.
Upon completion of this activity, the participant should be able to:
1. Review the underlying causes and risk factors contributing to meibomian gland dysfunction (MGD), Demodex blepharitis, inflammation, and corneal nerves in ocular surface disease (OSD).
2. Identify diagnostic tools and techniques used to assess eyelid margin health, inflammation, and corneal nerve integrity.
3. Examine current and emerging treatment options for managing eyelid margin health, inflammation, and corneal nerve health.
3. Develop strategies for discussing diagnosis, treatment options, and setting realistic expectations with patients.
Accreditation
Sponsored by
The Fundingsland Group, LLC is a COPE-Approved Administrator.
This activity, COPE Activity Number 131865, is accredited by COPE for continuing education for optometrists. This course is approved for 3.0 hours of CE.
Course # 101145-TD
Activity #: 131865
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Release Date: 11-28-2025
Expiration Date: 11-27-2026
Target Audience
This accredited educational activity is designed for optometrists.
Grant Support Statement
This activity is supported by unrestricted educational grants from Dompé, Harrow, Johnson & Johnson Vision, Sun Pharma, and Théa Pharma
Participation Method
In order to obtain credit: complete the pre-test, listen to the activity, successfully pass the post-test, and complete the evaluation. Only candidates with a passing score of at least 70% earn CE credit. Candidates have the opportunity to retake the post-test until a passing score is achieved. The course credit certificate will appear in the Certificates section of your account automatically upon successful completion of the course.
Faculty
Program Chairs / Hosts
Eyelid Margin Case Presentations
Corneal Nerve Health Presentation
Financial Relationship Disclosures
It is the policy of The Fundingsland Group (TFG) that faculty and other individuals in a position to control content of this activity disclose all financial relationships with ACCME defined ineligible companies within the past 24 months. TFG has policies in place that have identified relevant relationships and mitigated any real or apparent conflicts of interest prior to this educational activity.
Marc Bloomenstein, OD, Faculty, and Planner, has the following relevant financial relationships: Consultant: AbbVie, Azura, Lenz, OcuSoft, Reichert, Sydnexis, Topcon and Visus. Consultant & Speaker: Alcon, Bausch+Lomb, and Tarsus. Speaker: Sun Pharma.
Doug Devries, OD, Planner, has the following relevant financial relationships: Consultant: AbbVie, Asecula, and SBH. Consultant & Speaker: Alcon, Bausch+Lomb, Bio Tissue, BlephEx, Brill, Dompe, Harrow, Lenz, Lumenis, Sun, and Tarsus. Speaker: ANI, Azura, Bruder, Malinckrocdt, and Tenpoint.
Lindsey Bull, OD, Faculty, has the following relevant financial relationships: Consultant & Speaker: Abbvie and Lenz. Dr. Bull has disclosed the following non-relevant financial relationship. Consultant: Viatris (relationship has ended).
Mitch Ibach, OD, Faculty, has the following relevant financial relationships: Consultant: Abbvie, Allergan, C-Light, ICare, Tarsus, and Thea. Consultant & Speaker: Alcon, Bausch+Lomb, Dompe, Glaukos, and Zeiss. Stock, Private Company: Balance Ophthalmics.
Cory Lappin, OD, Faculty, has the following relevant financial relationships: Advisory Board: Eyenovia, Harrow, Nordic Pharma, and Vital Tears. Advisory Board, Consultant, & Speaker: Alcon, Bausch+Lomb, Bruder, and Tarsus. Advisory Board, Consultant & Executive Team Member: Myze. Consultant: CSI Dry Eye Software, Ocubio, Rinsada, SCOPE Health, Inc., Sight Sciences, Tear Restore, and Viatris. Consultant, Medical Director: Norwood Device and Diagnostics. Consultant & Speaker: Lumenis, and PRN Vision Group. Consultant & Stock, Private Company: Barti and NuLids. Speaker: Dompe
Laura Straub, Staff, has the following relevant financial relationships: Consultant: LaunchLab Partners, Powers and Company, MJM and Holliday Communications. The following financial relationships as a consultant have ended: Avisi Technologies, Nova Eye, Rayner, RxSight, STAAR Surgical and Zeiss.
All other Fundingsland Group staff, planners, reviewers, and writers have no financial relationships with ineligible companies.
All identified relevant financial relationships have been mitigated and the educational content thoroughly evaluated for fair, balanced, and safe, effective patient care.